Search results for " Basic"

showing 10 items of 10515 documents

Human somatic cells subjected to genetic induction with six germ line-related factors display meiotic germ cell-like features

2016

AbstractThe in vitro derivation of human germ cells has attracted interest in the last years, but their direct conversion from human somatic cells has not yet been reported. Here we tested the ability of human male somatic cells to directly convert into a meiotic germ cell-like phenotype by inducing them with a combination of selected key germ cell developmental factors. We started with a pool of 12 candidates that were reduced to 6, demonstrating that ectopic expression of the germ line-related genes PRDM1, PRDM14, LIN28A, DAZL, VASA and SYCP3 induced direct conversion of somatic cells (hFSK (46, XY) and hMSC (46, XY)) into a germ cell-like phenotype in vitro. Induced germ cell-like cells …

MaleTranscriptional Activation0301 basic medicineSomatic cellCellular differentiationForeskinCell Culture TechniquesMice NudeEmbryoid bodyHaploidyBiologyArticleGermline03 medical and health sciences0302 clinical medicinemedicineAnimalsHumansBusulfanCells CulturedGerm plasmGeneticsMultidisciplinaryCell DifferentiationDiploidySpermatogoniaCell biologyMeiosisGerm Cells030104 developmental biologymedicine.anatomical_structureGerm line developmentTranscriptomeReprogramming030217 neurology & neurosurgeryGerm cell
researchProduct

Vitamin D Receptor Activation Reduces Angiotensin-II–Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E–Knockout Mice

2015

Objective— Abdominal aortic aneurysm (AAA) is a vascular disorder characterized by chronic inflammation of the aortic wall. Low concentrations of vitamin D 3 are associated with AAA development; however, the potential direct effect of vitamin D 3 on AAA remains unknown. This study evaluates the effect of oral treatment with the vitamin D 3 receptor (VDR) ligand, calcitriol, on dissecting AAA induced by angiotensin-II (Ang-II) infusion in apoE −/− mice. Approach and Results— Oral treatment with calcitriol reduced Ang-II–induced dissecting AAA formation in apoE −/− mice, which was unrelated to systolic blood pressure or plasma cholesterol concentrations. Immunohistochemistry and reverse-tran…

MaleVascular Endothelial Growth Factor A0301 basic medicineDissecting Abdominal Aortic Aneurysm030204 cardiovascular system & hematologyLigandsCalcitriol receptorchemistry.chemical_compound0302 clinical medicineAorta AbdominalCells CulturedMice KnockoutAngiotensin IIVascular endothelial growth factorChemotaxis LeukocyteVascular endothelial growth factor APhenotypeMatrix Metalloproteinase 9Vitamin D3 ReceptorMatrix Metalloproteinase 2RNA Interferencelipids (amino acids peptides and proteins)ChemokinesMitogen-Activated Protein KinasesCardiology and Cardiovascular MedicineSignal Transductionmedicine.drugmedicine.medical_specialtyCalcitriolBiologyTransfectionProinflammatory cytokine03 medical and health sciencesApolipoproteins ECalcitriolInternal medicineHuman Umbilical Vein Endothelial CellsmedicineAnimalsHumansGenetic Predisposition to DiseaseRetinoid X Receptor alphaMacrophagesAngiotensin IIMice Inbred C57BLAortic DissectionDisease Models Animal030104 developmental biologyEndocrinologychemistryReceptors CalcitriolAortic Aneurysm AbdominalArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

Complement Activation in Peritoneal Dialysis–Induced Arteriolopathy

2017

Cardiovascular disease (CVD) is the leading cause of increased mortality in patients with CKD and is further aggravated by peritoneal dialysis (PD). Children are devoid of preexisting CVD and provide unique insight into specific uremia- and PD-induced pathomechanisms of CVD. We obtained peritoneal specimens from children with stage 5 CKD at time of PD catheter insertion (CKD5 group), children with established PD (PD group), and age-matched nonuremic controls (n=6/group). We microdissected omental arterioles from tissue layers not directly exposed to PD fluid and used adjacent sections of four arterioles per patient for transcriptomic and proteomic analyses. Findings were validated in omenta…

MaleVascular Endothelial Growth Factor A0301 basic medicinePathologyProteomemedicine.medical_treatmentComplement Membrane Attack ComplexSmad2 ProteinSeverity of Illness IndexTransforming Growth Factor betaMedicinePhosphorylationChildComplement ActivationCatheter insertionGeneral MedicineArteriosclerosisArteriolesComplement C3dNephrologyChild PreschoolFemaleOmentumPeritoneal DialysisSignal Transductionmedicine.medical_specialtyAdolescentPeritoneal dialysis03 medical and health sciencesDownregulation and upregulationClinical ResearchTGF beta signaling pathwayHumansSmad3 ProteinVascular DiseasesUremiabusiness.industryVascular diseaseComplement C1qInfant NewbornInfantComplement System Proteinsmedicine.diseaseUremiaComplement systemGene Ontology030104 developmental biologyCase-Control StudiesKidney Failure ChronicTranscriptomebusinessJournal of the American Society of Nephrology
researchProduct

How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016

2020

Purpose. To describe intravitreal anti-VEGF drug and dexamethasone use in four Italian regions. Methods. Four regional claims databases were used to measure drug prevalence, compare dosing intervals to those recommended in the summary of product characteristics (SPC), and identify switchers. Bilateral treatment and diabetic macular edema (DME) coding algorithms were validated, linking claims with a sample of prospectively collected ophthalmological data. Results. Overall, 41,836 patients received ≥1 study drug in 2010–2016 (4.8 per 10,000 persons). In 2016, anti-VEGF drug use ranged from 0.8 (Basilicata) to 5.7 (Lombardy) per 10,000 persons while intravitreal dexamethasone use ranged from 0…

MaleVascular Endothelial Growth Factor A0301 basic medicineintravitrealAngiogenesis Inhibitorsalgorithm.0302 clinical medicineMedicineSummary of Product Characteristicsmedia_commonAged 80 and overDrug ImplantsvalidationLaser CoagulationRGeneral MedicineMiddle AgedItalyanti-VEGF030220 oncology & carcinogenesisMedicineFemaleclinical dataoriginal articleResearch Articlemedicine.drugDrugmedicine.medical_specialtyArticle Subjectmedia_common.quotation_subjectMEDLINEdexamethasonePharmacyMacular EdemaGeneral Biochemistry Genetics and Molecular BiologyInsurance Claim Review03 medical and health sciencesRanibizumabInternal medicineHumansDosingDexamethasoneAgedDiabetic RetinopathyGeneral Immunology and MicrobiologySettore MED/30 - Malattie Apparato Visivobusiness.industryclaims database030104 developmental biologydrug utilisationMacular Edema; Ranibizumab; Laser CoagulationImplantRanibizumabbusinessBioMed Research International
researchProduct

De-novo Williams–Beuren and inherited Marfan syndromes in a patient with developmental delay and lens dislocation

2017

MaleWilliams Syndrome0301 basic medicinePediatricsmedicine.medical_specialtyGenotypeDevelopmental DisabilitiesFibrillin-1DNA Mutational AnalysisMarfan SyndromePathology and Forensic Medicine03 medical and health sciencesDislocation (syntax)medicineHumansChildAllelesIn Situ Hybridization FluorescenceGenetics (clinical)Myosin Heavy Chainsbusiness.industryFaciesGeneral MedicineLens SubluxationPhenotype030104 developmental biologymedicine.anatomical_structureLens (anatomy)MutationPediatrics Perinatology and Child HealthAnatomybusinessClinical Dysmorphology
researchProduct

Utility of lateral flow tests in SARS-CoV-2 infection monitorization

2020

Introduction. The diagnosis of SARS-CoV-2 infection is crucial for medical and public health reasons, to allow the best treatment of cases and the best control of the pandemic. Serology testing allows for the detection of asymptomatic infections and 19-COVID cases once the virus has been cleared. We analyzed the usefulness of the SARS-CoV-2 rapid test of Autobio and tried to correlate its pattern with the severity of COVID19 infection. Material and methods. We analyzed the accuracy and clinical usefulness of a point-of-care IgM and/or IgG test for SARS-CoV-2 in 35 COVID-19 patients [12 (34.3%) mild-moderate and 23 (65.7%) severe-critical] admitted to a field hospital in Madrid, as well as i…

Malebandas débilmente positivas0301 basic medicineTime FactorsOriginalCross-sectional studyinfección por COVID-19weak positive bandsDiseaseAntibodies ViralSeverity of Illness IndexSerologyCOVID-19 Testing0302 clinical medicineSerologic rapid tests030212 general & internal medicineAsymptomatic InfectionsImmunoassaybiologyReverse Transcriptase Polymerase Chain ReactionGeneral MedicineMiddle AgedPoint-of-Care TestingFemaleSymptom Assessmentmedicine.symptomAntibodyCoronavirus InfectionsAdultMicrobiology (medical)medicine.medical_specialtyPoint-of-care testingPneumonia ViralSensitivity and SpecificityAsymptomaticVirusBetacoronavirus03 medical and health sciencesInternal medicineSeverity of illnessmedicineHumanstest serológicos rápidosPandemicsAgedPharmacologyClinical Laboratory TechniquesSARS-CoV-2business.industryCOVID-19COVID-19 infectionCross-Sectional Studies030104 developmental biologyImmunoglobulin MAutobioImmunoglobulin Gbiology.proteinbusinessRevista Española de Quimioterapia
researchProduct

Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation

2018

Sirolimus appears to protect against cytomegalovirus (CMV) in organ transplant recipients. The effect of this drug in allogeneic hematopoietic stem cell transplantation recipients remains unexplored. By means of multivariate continuous-time Markov model analyses, we identified 3 independent covariates that significantly impacted the risk of CMV DNAemia: recipient/donor CMV serostatus, tacrolimus exposure, and sirolimus exposure. CMV-seropositive recipients with CMV-seronegative donors had a significantly higher probability of having detectable CMV DNAemia. Increasing the tacrolimus trough concentration from 0 to 16 ng/mL increased the probability of patients having detectable CMV DNAemia by…

Malebasic (laboratory) research/science0301 basic medicinemedicine.medical_treatmentCytomegalovirusHematopoietic stem cell transplantationGastroenterologyOrgan transplantation0302 clinical medicineRisk FactorsImmunology and AllergyPharmacology (medical)Whole bloodIncidenceHematopoietic Stem Cell Transplantationvirus diseasesMiddle AgedPrognosissurgical procedures operativeCytomegalovirus Infectionscytomegalovirus (CMV) [infection and infectious agents-viral]Femaleantiviral [antibiotic]pharmacokinetics/pharmacodynamicsImmunosuppressive Agentsmedicine.drugAdultmedicine.medical_specialtyinfectious diseasesirolimus [immunosuppressant-mechanistic target of rapamycin]clinical research/practicetacrolimus [immunosuppressant-calcineurin inhibitor]03 medical and health sciencesInternal medicinemedicineHumansTransplantation HomologousTrough ConcentrationViremiabone marrow/hematopoietic stem cell transplantationAgedSirolimusTransplantationbusiness.industryTransplant RecipientsTacrolimus030104 developmental biologySpainRelative riskSirolimusDNA ViralpharmacologybusinessSerostatusFollow-Up Studies030215 immunology
researchProduct

Influence of diet in urinary levels of metals in a biomonitoring study of a child population of the Valencian region (Spain)

2018

[EN] Pollution by trace elements and its possible effect on organisms has become a worldwide concern due to the increasing presence of trace elements in the environment and especially in the food chain. Exposure to chemicals has traditionally been measured using environmental samples, however, human biomonitoring brings a different perspective, in which all sources and exposure pathways are integrated. The objective of this paper is to discern the possible relationship between children's diet and the metals found in children urine. With this aim in mind, a total of 120 voluntaries participated in a diet survey carried out in a school-aged population (age 6-11) from the Valencian region. In …

Maleinorganic chemicals0301 basic medicineEnvironmental EngineeringTECNOLOGIA DE ALIMENTOSESTADISTICA E INVESTIGACION OPERATIVAPopulationchemistry.chemical_elementUrineUrine010501 environmental sciencesDiet Surveys01 natural sciencesDietary Exposure03 medical and health sciencesBiomonitoringHumansEnvironmental ChemistryChildeducationChildrenWaste Management and DisposalArsenic0105 earth and related environmental sciencesCadmiumeducation.field_of_studyPollutionDietMercury (element)030104 developmental biologychemistrySpainMetalsEnvironmental chemistryBiomonitoringThalliumEnvironmental PollutantsFemaleSeleniumEnvironmental MonitoringScience of The Total Environment
researchProduct

Eliminating Factor H-Binding Activity of Borrelia burgdorferi CspZ Combined with Virus-Like Particle Conjugation Enhances Its Efficacy as a Lyme Dise…

2018

The spirochete Borrelia burgdorferi is the causative agent of Lyme disease, the most common tick-borne disease in the U.S and Europe. No potent human vaccine is currently available. The innate immune complement system is vital to host defense against pathogens, as complement activation on the surface of spirochetes results in bacterial killing. Complement system is inhibited by the complement regulator factor H. To escape killing, B. burgdorferi produces an outer surface protein CspZ that binds factor H to inhibit complement activation on the cell surface. Immunization with CspZ alone does not protect mice from infection, which we speculate is because factor H-binding cloaks potentially pro…

Malelcsh:Immunologic diseases. Allergy0301 basic medicine030106 microbiologyImmunologySerum Bactericidal Antibody Assayvirus-like particlesEpitopeMicrobiologyMice03 medical and health sciencesAntigenvaccineBorreliaAnimalsLyme diseaseImmunology and AllergyVaccines Virus-Like Particleddc:610Borrelia burgdorferiOriginal ResearchInnate immune systembiologyBorreliaImmunogenicityImmunization PassiveLyme Disease Vaccinesfactor Hbiology.organism_classificationAntibodies Bacterial3. Good healthComplement systemCspZ030104 developmental biologyBorrelia burgdorferiComplement Factor Hbiology.proteinAntibodylcsh:RC581-607Bacterial Outer Membrane ProteinsFrontiers in Immunology
researchProduct

Outcomes After Vascular Surgery Procedures in Patients with COVID-19 Infection: A National Multicenter Cohort Study (COVID-VAS)

2021

Objectives To analyze the outcome of vascular procedures performed in patients with COVID-19 infection during the 2020 pandemic. Methods This is a multicenter, prospective observational cohort study. We analyzed data from 75 patients with COVID-19 infection undergoing vascular surgery procedures in 17 hospitals across Spain and Andorra between March and May 2020. The primary end point was 30-day mortality. Clinical Trials registry number NCT04333693. Results The mean age was 70.9 (45–94) and 58 (77.0%) patients were male. Around 70.7% had postoperative complications, 36.0% of patients experienced respiratory failure, 22.7% acute renal failure, and 22.7% acute respiratory distress syndrome (…

Malemedicine.medical_specialtyARDS030204 cardiovascular system & hematology030218 nuclear medicine & medical imagingClinical Research Basic ScienceSepsisCohort Studies03 medical and health sciencesAndorra0302 clinical medicinePostoperative ComplicationsRisk FactorsInternal medicinemedicineHumansLymphocyte CountRisk factorAgedAged 80 and overAnalysis of VarianceRespiratory Distress SyndromeL-Lactate Dehydrogenasebusiness.industryMortality rateAcute kidney injuryAge FactorsCOVID-19General MedicineVascular surgeryAcute Kidney InjuryMiddle Agedmedicine.diseasePrognosisTreatment OutcomeRespiratory failureSpainSurgeryFemalebusinessCardiology and Cardiovascular MedicineVascular Surgical ProceduresCohort studyAnnals of Vascular Surgery
researchProduct